Stockscreener 앱 받기
1.47
8.89%
0.12
시간 외 거래:
1.35
-0.12
-8.16%
Vivos Therapeutics Inc 주식(VVOS)의 최신 뉴스
Vivos Therapeutics Pivots to Medical-Provider Focused Model with Sleep Center of Nevada Acquisition to Expand Sleep Apnea Solutions 91 - Minichart
Earnings call transcript: vivos beats Q4 2025 earnings expectations - Investing.com
Vivos Therapeutics (NASDAQ: VVOS) grows 2025 revenue as net loss widens - Stock Titan
Vivos Therapeutics (NASDAQ: VVOS) details SCN deal and new sleep-center strategy - Stock Titan
Vivos Therapeutics Reports Full Year 2025 Financial Results - marketscreener.com
Vivos grows on sleep apnea services, but operating loss hits $19.9M - Stock Titan
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results - National Today
Vivos Therapeutics, Inc. to Release Full Year 2025 Financial Results and Conduct Conference Call on April 15, 2026 - Quiver Quantitative
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call - marketscreener.com
Vivos investors get 2025 results and strategy update at 5 p.m. ET - Stock Titan
Broadcom, Vivos Therapeutics and 3 stocks to watch heading into Monday - MSN
New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ - ACCESS Newswire
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX) - Hilton Head Island Packet
Vivos Therapeutics (VVOS) 10% holder reports large stock and warrant stakes - Stock Titan
VVOS Stock Chart | VIVOS THERAPEUTICS INC (NASDAQ:VVOS) - ChartMill
Resistance Check: Can Vivos Therapeutics Inc maintain its current growth rate2026 Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
VVOS|Vivos Therapeutics Inc|Price:1.190|Chg%:-0.05 - TradingKey
VVOS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Vivos Therapeutics closes $2.25M private placement with Seneca By Investing.com - Investing.com Canada
Vivos Therapeutics closes $2.25M private placement with Seneca - Investing.com
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners - marketscreener.com
Portfolio Update: How does Vivos Therapeutics Inc score in quality rankingsTrade Exit Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Broadcom, Vivos Therapeutics And 3 Stocks To Watch Heading Into Monday - Sahm
Vivos Therapeutics Enters Securities Purchase Agreement with V-CO Investors 3 LLC and Issues New Warrants – Form 8-K Filing Details - Minichart
VVOS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
VVOS Technical Analysis & Stock Price Forecast - Intellectia AI
If You Invested $1,000 in Vivos Therapeutics Inc (VVOS) - Stock Titan
Vivos Therapeutics Completes Private Placement to Bolster Liquidity - TipRanks
Vivos Therapeutics Secures $0.85M PIPE, Converts $1.4M Bridge Note With Seneca Affiliate - TradingView — Track All Markets
Vivos Therapeutics (NASDAQ: VVOS) gets $850,000 PIPE cash plus $1,400,000 bridge note conversion - Stock Titan
Why did Vivos Therapeutics (VVOS) stock jump over 21% after hours - MSN
Form 8-KCurrent report - ADVFN
Vivos Therapeutics investor V-Co investors 3 LLC buys shares worth $1.8m By Investing.com - Investing.com
Why Did Vivos Therapeutics (VVOS) Stock Jump Over 21% After Hours - Benzinga
VVOS | Vivos Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
Vivos Therapeutics (NASDAQ: VVOS) investor buys stock, pre-funded warrants - Stock Titan
Michael C. Skaff Discloses Investment at Vivos Therapeutics with 19.9% Stake - TradingView — Track All Markets
Investor group (NASDAQ: VVOS) funds Vivos with $2.39M PIPE and warrants - Stock Titan
Vivos Therapeutics Delays Annual Filing Amid Expansion - TipRanks
Vivos Therapeutics’ Supported Practices Achieve In-Network Status in Nevada - Sleep Review
Vivos Therapeutics (NASDAQ: VVOS) delays 2025 Form 10-K, cites SCN acquisition - Stock Titan
Buyback Watch: What are Vivos Therapeutics Incs earnings expectations2026 Recap & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Vivos Therapeutics, Inc. announced that it has received $2.389957 million in funding from V-Co Investors 3 LLC - marketscreener.com
Vivos Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Earnings Risk: Can Vivos Therapeutics Inc withstand a market correction2026 Drop Watch & Breakout Confirmation Alerts - baoquankhu1.vn
Vivos Therapeutics Inc (referred to as Vivos Therapeutics) recently disclosed a comprehensive cost optimization strategy. - Bitget
Vivos Therapeutics gains Nevada insurance network access By Investing.com - Investing.com Canada
Vivos Therapeutics gains Nevada insurance network access - Investing.com
2.40%
0.00%
자본화:
|
볼륨(24시간):